# FDA Inspection 1243567 - Aspirus - Wausau Hospital - May 14, 2024

Source: https://www.keypedia.com/records/fda_inspections/aspirus-wausau-hospital/bebe6a7b-18c8-4909-bd96-1448cda9c9f7
Source feed: FDA_Inspections

> FDA Inspection 1243567 for Aspirus - Wausau Hospital on May 14, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1243567
- Company Name: Aspirus - Wausau Hospital
- Inspection Date: 2024-05-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1064675 - 2018-08-31](https://www.keypedia.com/records/fda_inspections/aspirus-wausau-hospital/1de2337f-66cf-4edf-bd55-f556ec348e7f)
- [FDA Inspection 958130 - 2016-01-13](https://www.keypedia.com/records/fda_inspections/aspirus-wausau-hospital/7877dadd-822a-4d6c-bc01-6797780dd0f8)
- [FDA Inspection 883477 - 2014-05-22](https://www.keypedia.com/records/fda_inspections/aspirus-wausau-hospital/5b4c4973-fe54-46f3-900e-426612f4e7a2)
- [FDA Inspection 756332 - 2011-11-14](https://www.keypedia.com/records/fda_inspections/aspirus-wausau-hospital/a6a760b8-b515-4241-80a6-a4634863779f)
- [FDA Inspection 667432 - 2010-06-15](https://www.keypedia.com/records/fda_inspections/aspirus-wausau-hospital/2670f12c-0739-455c-a90a-25fd3cdab695)

Company: https://www.keypedia.com/companies/aspirus-wausau-hospital/b879436c-2c92-405b-a8d4-a99bf6e265b9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d